Lund University Hospital

This trial tests whether proton therapy causes fewer side effects than standard photon radiation in people with early tonsil cancer. About 100 patients will be randomly assigned to receive one of the two radiation types, both aimed at curing the cancer. Researchers will track acu…

This phase 2 trial tests whether combining pemigatinib, an FGFR inhibitor, with retifanlimab, a PD-1 inhibitor, can slow tumor growth in people with advanced dedifferentiated liposarcoma (DDLPS), an aggressive soft tissue cancer. The study enrolls adults whose disease has progres…

This phase III trial tests whether adding radiation to the lymph nodes improves outcomes for men whose prostate cancer has returned after prostatectomy, indicated by a rising PSA. About 374 participants with low PSA levels will receive either standard radiation to the prostate be…

This phase 3 trial tests whether personalizing the schedule of a radioactive drug (177Lu-DOTATOC) improves outcomes for people with advanced neuroendocrine tumors. About 300 participants will receive either a standard or personalized treatment plan, with some also taking capecita…

This study looks at blood and skin samples from people with mycosis fungoides and Sézary syndrome, rare types of lymphoma that affect the skin. Researchers want to find biological markers that can predict how the disease will progress and how well a patient might respond to treat…

This study looks at whether standard, off-the-shelf jaw joint implants can be planned using 3D virtual software, just like expensive custom implants. Researchers will review X-rays from 30 patients who already had TMJ replacement surgery to see if virtual planning with standard i…

This study is tracking 2,000 people with metastatic breast cancer to understand how the cancer changes over time and in response to treatment. Researchers will analyze tumor and blood samples to find genetic markers that predict which therapies work best. The goal is to develop b…